GSK plc Increase Decrease Through Changes In Foreign Exchange Rates Net Defined Benefit Liability Asset
GSK plc (GSK) reported Increase Decrease Through Changes In Foreign Exchange Rates Net Defined Benefit Liability Asset of -GBP 11.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset · last filed 2026-03-06
| Period end | Increase Decrease Through Changes In Foreign Exchange Rates Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2025-12-31 | -11.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | -14.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | -44.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 87.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | -65.00M GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 18.00M GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | -87.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 47.00M GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | -40.00M GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | 218.00M GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 11.00M GBP 20-F/A · filed 2018-03-20 |